ATE283481T1 - Verfahren zum auffinden von reagenzien und festphasenkomponenten in spezifischen bindungsassays, frei von fortgeschrittenen glykosylierungsendprodukten - Google Patents

Verfahren zum auffinden von reagenzien und festphasenkomponenten in spezifischen bindungsassays, frei von fortgeschrittenen glykosylierungsendprodukten

Info

Publication number
ATE283481T1
ATE283481T1 AT02006303T AT02006303T ATE283481T1 AT E283481 T1 ATE283481 T1 AT E283481T1 AT 02006303 T AT02006303 T AT 02006303T AT 02006303 T AT02006303 T AT 02006303T AT E283481 T1 ATE283481 T1 AT E283481T1
Authority
AT
Austria
Prior art keywords
solid phase
free
reagents
finding
specific binding
Prior art date
Application number
AT02006303T
Other languages
English (en)
Inventor
Rosemarie Dr Kientsch-Engel
Andreas Dr Gallusser
Werner Dr Naser
Helmut Dr Lill
Peter Dr Stahl
Theresa Kott
Josef Maier
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE283481T1 publication Critical patent/ATE283481T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/02—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates involving antibodies to sugar part of glycoproteins

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT02006303T 2001-03-22 2002-03-20 Verfahren zum auffinden von reagenzien und festphasenkomponenten in spezifischen bindungsassays, frei von fortgeschrittenen glykosylierungsendprodukten ATE283481T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01107155 2001-03-22

Publications (1)

Publication Number Publication Date
ATE283481T1 true ATE283481T1 (de) 2004-12-15

Family

ID=8176894

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02006303T ATE283481T1 (de) 2001-03-22 2002-03-20 Verfahren zum auffinden von reagenzien und festphasenkomponenten in spezifischen bindungsassays, frei von fortgeschrittenen glykosylierungsendprodukten

Country Status (5)

Country Link
US (1) US20030073138A1 (de)
JP (1) JP3646097B2 (de)
AT (1) ATE283481T1 (de)
DE (1) DE60202008T2 (de)
ES (1) ES2231601T3 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7816090B2 (en) * 2007-01-10 2010-10-19 Ortho-Clinical Diagnostics, Inc. Multiple immunochemistry assays on an element
HUE031902T2 (en) * 2008-05-23 2017-08-28 Siwa Corp Procedures and Preparations to Promote Regeneration
US9649376B2 (en) 2010-09-27 2017-05-16 Siwa Corporation Selective removal of age-modified cells for treatment of atherosclerosis
US8721571B2 (en) 2010-11-22 2014-05-13 Siwa Corporation Selective removal of cells having accumulated agents
DE102011003944A1 (de) 2011-02-10 2012-08-16 Oxprotect Gmbh Detektion und Entfernung von missgefalteten Proteinen/Peptiden
CA2961603C (en) 2014-09-19 2021-07-13 Siwa Corporation Anti-age antibodies for treating inflammation and auto-immune disorders
US9993535B2 (en) 2014-12-18 2018-06-12 Siwa Corporation Method and composition for treating sarcopenia
US10358502B2 (en) 2014-12-18 2019-07-23 Siwa Corporation Product and method for treating sarcopenia
KR102786111B1 (ko) 2016-02-19 2025-03-26 시와 코퍼레이션 고급 당화 최종 산물(age)에 대한 항체를 사용하여 암을 치료하고, 전이성 암 세포를 사멸시키고, 암 전이를 예방하기 위한 방법 및 조성물
AU2017250301A1 (en) 2016-04-15 2018-11-15 Siwa Corporation Anti-age antibodies for treating neurodegenerative disorders
WO2017222535A1 (en) 2016-06-23 2017-12-28 Siwa Corporation Vaccines for use in treating various diseases and disorders
US10858449B1 (en) 2017-01-06 2020-12-08 Siwa Corporation Methods and compositions for treating osteoarthritis
US10961321B1 (en) 2017-01-06 2021-03-30 Siwa Corporation Methods and compositions for treating pain associated with inflammation
US10925937B1 (en) 2017-01-06 2021-02-23 Siwa Corporation Vaccines for use in treating juvenile disorders associated with inflammation
US10995151B1 (en) 2017-01-06 2021-05-04 Siwa Corporation Methods and compositions for treating disease-related cachexia
EP3609923A1 (de) 2017-04-13 2020-02-19 Siwa Corporation Humanisierter monoklonaler advanced-glycation-endproduct-antikörper
US11518801B1 (en) 2017-12-22 2022-12-06 Siwa Corporation Methods and compositions for treating diabetes and diabetic complications

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5318982A (en) * 1984-03-19 1994-06-07 The Rockefeller University Inhibition of the advanced glycosylation of proteins using substituted-1,2,4-triazoles
US4829009A (en) * 1986-02-21 1989-05-09 The Regents Of The University Of California Noise controlled immunoassays
US5624804A (en) * 1991-12-20 1997-04-29 The Rockefeller University Immunochemical detection of In vivo advanced glycosylation end products
US5610076A (en) * 1994-04-29 1997-03-11 Alteon Inc. Method for detecting hemoglobin advanced glycosylation endproducts
US5744318A (en) * 1994-12-30 1998-04-28 Alteon Inc. Monoclonal antibody for the detection of advanced glycosylation endproducts in biological samples
US5855882A (en) * 1995-04-05 1999-01-05 The Picower Institute For Medical Research Methods for inhibiting the cross-linking of advanced glycosylation endproducts
US6380165B1 (en) * 1997-09-19 2002-04-30 The Picower Institute For Medical Research Immunological advanced glycation endproduct crosslink
EP1354206A2 (de) * 2000-12-13 2003-10-22 Bio-Rad Laboratories, Inc. Standard-verdünnungsmittel für multiplex-bestimmungen

Also Published As

Publication number Publication date
ES2231601T3 (es) 2005-05-16
US20030073138A1 (en) 2003-04-17
JP2002357608A (ja) 2002-12-13
JP3646097B2 (ja) 2005-05-11
DE60202008D1 (de) 2004-12-30
DE60202008T2 (de) 2005-12-01

Similar Documents

Publication Publication Date Title
DE60202008D1 (de) Verfahren zum Auffinden von Reagenzien und Festphasenkomponenten in spezifischen Bindungsassays, frei von fortgeschrittenen Glykosylierungsendprodukten
EP1379693A4 (de) Auf oligonukleotid-modifizierten partikeln basierende bio-strichcodes
WO2005003394A3 (en) Bio-barcode based detection of target analytes
ATE250143T1 (de) Verfahren und vorrichtung zum nachweis und zur quantifizierung von biomolekülen
DE60230927D1 (de) Fangverbindungen, ihre entnahme und verfahren zur analysierung des proteoms und von komplexen zusammensetzungen
DE60223635D1 (de) Reagenzien, Verfahren und Vorrichtungen zum Nachweis von Analyten
ATE478342T1 (de) Kompakte vorrichtung, zusammensetzungen und verfahren zur reinigung von nukleinsäuren
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE337855T1 (de) Verfahren und vorrichtung zur vorbehandlung von proben durch zentrifugieren
DE69710077D1 (de) Verfahren zur erkennung von verbindungen, die die interaktion von rna und rna-bindeproteinen beeinflussen
DE60029957D1 (de) Verfahren und kit zum nachweis von betalactam enthaltenden verbindungen
ATE206211T1 (de) Linker-system zum aktivieren von oberflächen für die biokonjugation und verfahren zu ihrer verwendung
ATE362530T1 (de) Verfahren und vorrichtung zur reinigung von nukleinsäuren
ATE314385T1 (de) Verfahren zur gewinnung von nukleinsäuren mit hilfe chaotroper-und ammoniumreagentien
DE60332382D1 (de) Zentrifugalvorrichtung und verfahren zur durchführung von bindungsversuchen
WO2004057336A3 (en) Use of nicotinamide n-methyltransferase as a marker for colorectal cancer
DE60122411D1 (de) Verfahren und Vorrichtung zur Konzentrationsbestimmung von einer Lösung, und Vorrichtung zur Verdünnung und Vorbereitung von Reagenzen
DE50114800D1 (de) Verfahren zur analyse von makromolekülen
WO2001051669A3 (en) Nucleic acid binding assay and selection method
ATE319735T1 (de) Aufreinigung von substanzen aus einer biologischen probe
ATA3372001A (de) Verfahren zur detektion von nukleinsäuremolekülen
DE59606129D1 (de) Verfahren und verbindungen zur detektion von analyten mittels remanenzmessung und deren verwendung
ATE408710T1 (de) Nachweis von legionella durch ein pcr und fret verwendendes verfahren
DE50114320D1 (de) Verfahren zur selektion hochaffin an ein target bindender nukleinsäuren durch zweidimensionale auftrennung
WO2003027681A3 (en) A method of protein analysis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1243924

Country of ref document: EP

REN Ceased due to non-payment of the annual fee